心境与精神病性障碍的性别依赖共享与非共享遗传结构
该研究对85,735例病例(33,403例SCZ、19,924例BIP、32,408例MDD)和109,946例对照进行了迄今最大规模的全基因组基因-性别(G×S)交互分析,发现跨障碍存在显著遗传重叠,但在变异、基因和通路水平上,性别依赖效应富集于神经发育、免疫和血管功能相关基因。
要点
- 跨障碍检测到NKAIN2位点全基因组显著SNP-性别交互(rs117780815,p=3.2×10-8),提示神经元兴奋性。
- 三个额外位点显示跨障碍G×S交互证据(p<1×10-6),涉及多种功能。
- MDD中血管内皮生长因子受体信号通路基因显示显著G×S交互(FDR校正p<.05)。
核心结论
- 心境与精神病性障碍存在大量跨性别遗传重叠,但性别依赖效应在变异、基因和通路水平富集于神经发育、免疫和血管功能相关基因。
研究设计与样本
- 基于PGC和iPSYCH的85,735例病例(33,403例SCZ、19,924例BIP、32,408例MDD)和109,946例对照的全基因组基因-性别交互分析。
主要发现
- 跨障碍检测到NKAIN2位点全基因组显著SNP-性别交互(rs117780815,p=3.2×10-8)。
- 三个额外位点显示跨障碍G×S交互证据(rs7302529,p=1.6×10-7;rs73033497,p=8.8×10-7;rs7914279,p=6.4×10-7)。
- 基于基因分析发现跨障碍G×S交互与转录抑制因子SLTM相关(p=8.97×10-7)。
- SCZ中最显著的是MOCOS基因位点(rs11665282,p=1.5×10-7),提示血管内皮细胞。
- PGC-SCZ二次分析检测到IDO2位点交互(rs13265509,p=1.1×10-7),IDO2为犬尿氨酸通路酶。
关键数值与推荐
- 跨障碍G×S交互全基因组显著阈值:p=3.2×10-8(NKAIN2位点rs117780815)。
- 额外位点交互证据阈值:p<1×10-6(rs7302529、rs73033497、rs7914279)。
- 基因水平G×S交互:SLTM,p=8.97×10-7。
- SCZ中MOCOS位点:rs11665282,p=1.5×10-7。
- MDD通路富集:VEGFR信号通路基因G×S交互,FDR校正p<.05。
临床怎么用
- 提示临床评估心境与精神病性障碍时需考虑性别特异的遗传风险背景。
- 神经发育、免疫和血管功能相关基因的性别依赖效应可能为未来性别分层诊疗提供线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sex differences in incidence and/or presentation of schizophrenia (SCZ), major depressive disorder (MDD), and bipolar disorder (BIP) are pervasive. Previous evidence for shared genetic risk and sex differences in brain abnormalities across disorders suggest possible shared sex-dependent genetic risk. METHODS: We conducted the largest to date genome-wide genotype-by-sex (G×S) interaction of risk for these disorders using 85,735 cases (33,403 SCZ, 19,924 BIP, and 32,408 MDD) and 109,946 controls from the PGC (Psychiatric Genomics Consortium) and iPSYCH. RESULTS: Across disorders, genome-wide significant single nucleotide polymorphism-by-sex interaction was detected for a locus encompassing NKAIN2 (rs117780815, p = 3.2 × 10-8), which interacts with sodium/potassium-transporting ATPase (adenosine triphosphatase) enzymes, implicating neuronal excitability. Three additional loci showed evidence (p < 1 × 10-6) for cross-disorder G×S interaction (rs7302529, p = 1.6 × 10-7; rs73033497, p = 8.8 × 10-7; rs7914279, p = 6.4 × 10-7), implicating various functions. Gene-based analyses identified G×S interaction across disorders (p = 8.97 × 10-7) with transcriptional inhibitor SLTM. Most significant in SCZ was a MOCOS gene locus (rs11665282, p = 1.5 × 10-7), implicating vascular endothelial cells. Secondary analysis of the PGC-SCZ dataset detected an interaction (rs13265509, p = 1.1 × 10-7) in a locus containing IDO2, a kynurenine pathway enzyme with immunoregulatory functions implicated in SCZ, BIP, and MDD. Pathway enrichment analysis detected significant G×S interaction of genes regulating vascular endothelial growth factor receptor signaling in MDD (false discovery rate-corrected p < .05). CONCLUSIONS: In the largest genome-wide G×S analysis of mood and psychotic disorders to date, there was substantial genetic overlap between the sexes. However, significant sex-dependent effects were enriched for genes related to neuronal development and immune and vascular functions across and within SCZ, BIP, and MDD at the variant, gene, and pathway levels.
引用
- Blokland GAM, Grove J, Chen CY, et al. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders. Biol Psychiatry. 2021. PMID: 34099189. doi:10.1016/j.biopsych.2021.02.972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。